Back

Predictive parameters for cardiovascular events in patients affected by multiple myeloma treated with carfilzomib

6 December 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Echocardiography, Other Echocardiography, Other EACVI Premium Access EuroEcho-Imaging 2018

About the speaker

Photo
Doctor Giulia Bruno

Mayo Clinic, Rochester (United States of America)

14 More presentations in this session

Presentation thumbnail
Doctor D. Morales (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Doctor S. Rettegno (Turin, IT)
Abstract
Presentation thumbnail
Mr M. Krestjyaninov (Ulyanovsk, RU)
Abstract Slides
Presentation thumbnail
Doctor G. Baldenhofer (Berlin, DE)
Abstract
Presentation thumbnail
Doctor N. Kouris (Magoula-Athens, GR)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Echocardiography, Other

The Event

Event poster

EuroEcho-Imaging 2018

6 December 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events
12 December 2020
thumbnail
Congress Session
Emerging insights in cardio-oncology: biomarkers, cardiotoxicity, and protective therapies
20 May 2025
thumbnail
Congress Presentation
Acute heart failure and cardiogenic shock: the cardiac side of multiple myeloma
24 March 2023
thumbnail
Congress Presentation
The impact of cardiac amyloidosis on patients with multiple myeloma: a systematic review and prognostic meta-analysis
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources